Organ On Chip Market: By Technology (Microfluidics-based Organ-on-Chip, 3D Bioprinting-based Organ-on-Chip, Other), By Organ Types ( Liver-on-Chip, Brain-on-Chip, Lung-on-Chip, Heart-on-Chip, Kidney-on-Chip, Other types), By Application (Drug Discovery, Toxicology Research, Physiological Model Development, Disease Modelling, Personalized Medicine), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Cosmetics Industry, Healthcare Providers) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Organ On Chip Market size was valued at USD 116.4 million in 2023 and is poised to grow at a CAGR of 32.1% from 2024 - 2030. Organ-on-chip (OOC) refers to a technology that replicates the activities, mechanics, and physiological responses of entire organs or organ systems on a microscale device. The primary goal of organ-on-chip technology is to provide a more accurate representation of human physiology compared to traditional cell cultures and animal models. There is a growing demand for alternatives to animal testing in pharmaceutical and biotechnology industries. Organ-on-chip technology offers a more ethical and accurate approach to studying human physiology and disease mechanisms compared to traditional methods.

Moreover, continuous technological advancements, such as 3D bioprinting, microfluidics, and sensor integration are the convenience provided by using this product are enhancing the capabilities and applicability of organ-on-chip models. These advancements improve the accuracy, efficacy, reproducibility, and complexity of organ-on-chip systems, making them more reliable for drug testing and disease modelling. Adding to that, FDA's interest in advancing organ-on-chip technology also plays as an important driver for this market. Although, it’s welcomed the initial investment and operational costs associated, technological complexity, validation standardization of organ-on-chip models across different laboratories, and limited interoperability between different organ-on-chip systems remain as hurdles to the market. Even though it offers an ethical advantage, when it comes to using of human cells ethical considerations and regulatory requirements for approval, pose challenges. There is also increasing pressure from society and governments to find alternatives to animal testing, as evidenced by the US Food and Drug Administration (FDA) Modernization Act of 2021 and the Humane Research and Testing Act (HR 1744). The FDA’s Innovative Science and Technology Approaches for New Drugs (ISTAND) pilot program, which has established similar qualification programs for drug development tools, including organ chips

Organ On Chip Market Key Developments:
  • In April 2024, CN Bio Innovations Ltd. secured $21 million in the initial closing of its Series B investment round and was chosen for the NC3Rs SensOoChip Challenge, tasked with developing advanced Heart-on-Chip technology.
  • In January 2024, CN Bio Innovations Ltd. and Altis Biosystems joined forces to develop a human gut/liver in vitro model for advanced absorption, distribution, metabolism, and excretion (ADME) studies.

Organ On Chip Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.5%

Largest Market

North-America

Fastest Growing Market

North-America
Organ On Chip Market Dynamics

The COVID-19 pandemic has accelerated the demand for rapid, accurate, and scalable models for drug testing and vaccine development. Organ-on-chip technologies have played a crucial role in supporting these efforts, enhancing their visibility and adoption. Moreover, expansion into multi-organ systems as these systems simulate interactions between different organs, AI-driven data analysis, and machine learning are being integrated with OOC platforms and disease modeling for complex diseases such as cancer, cardiovascular diseases, neurodegenerative disorders are the recent trends of organ-on-chips market very new and still evolving, the whole market is adapting to current application such as drug toxicity testing, personalized medicine, and precision therapeutics. In addition, increased collaborations between pharmaceutical firms are driving innovation in OOC technology, companies trying to enter emerging markets such as Asia-Pacific, increasing efforts by companies to commercialize organ-on-chip, and establishing new and relevant guidelines for approval from regulatory bodies are the main opportunities for companies in this market.

Organ On Chip Market Segmentation

By Technology
  • Microfluidics-based Organ-on-Chip
  • 3D Bioprinting-based Organ-on-Chip
  • Other
By Organ Types
  • Liver-on-Chip
  • Brain-on-Chip
  • Lung-on-Chip
  • Heart-on-Chip
  • Kidney-on-Chip
  • Other Types
By Application
  • Drug Discovery
  • Toxicology Research
  • Physiological Model Development
  • Disease Modelling
  • Personalized Medicine
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Cosmetics Industry
  • Healthcare Providers
  • Others

Frequently Asked Questions

Organ On Chip Market size was valued at USD 116.4 million in 2023 and is poised to grow at a CAGR of 32.1% from 2024 - 2030

The main players in the Organs-on-chips (OOC) Market are Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Draper Laboratory, Hesperos Inc., Nortis, Kirkstall, Altis Biosystems, Xona Microfluidics, SynVivo, Inc., Axosim Technologies.

Demand for ethical alternatives, continuous technological advancements, such as 3d bioprinting, microfluidics, and sensor integration, efficiency and reliability of the models, increasing recognition and support from regulatory agencies such as FDA, rising healthcare expenditure are the main drivers of the market.

North America is projected to lead the global Organ on Chip market as the presence of robust research and healthcare infrastructure and substantial funding compared the rest of the world.

Key Features of the Reports

  • The organ on chip market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global Organ On Chip Market Introduction 
2.1.Global Organ On Chip Market  - Taxonomy
2.2.Global Organ On Chip Market  - Definitions
2.2.1.Product Type
2.2.2.Organ Types
2.2.3. Application
2.2.4.End-user
2.2.5.Region
3.Global Organ On Chip Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Organ On Chip Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Organ On Chip Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Microfluidics-based Organ-on-Chip
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. 3D Bioprinting-based Organ-on-Chip
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Other
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Organ On Chip Market  By Organ Types, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Liver-on-Chip
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Brain-on-Chip
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Lung-on-Chip
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Heart-on-Chip
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Kidney-on-Chip
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Other Types
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7.Global Organ On Chip Market  By  Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Drug Discovery
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Toxicology Research
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Physiological Model Development
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Disease Modelling
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Personalized Medicine
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Organ On Chip Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Academic and Research Institutes
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Cosmetics Industry
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Healthcare Providers
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Others
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.Global Organ On Chip Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Organ On Chip Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Microfluidics-based Organ-on-Chip
10.1.2.3D Bioprinting-based Organ-on-Chip
10.1.3.Other
10.2.  Organ Types Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Liver-on-Chip
10.2.2.Brain-on-Chip
10.2.3.Lung-on-Chip
10.2.4.Heart-on-Chip
10.2.5.Kidney-on-Chip
10.2.6.Other Types
10.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Drug Discovery
10.3.2.Toxicology Research
10.3.3.Physiological Model Development
10.3.4.Disease Modelling
10.3.5.Personalized Medicine
10.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Pharmaceutical and Biotechnology Companies
10.4.2.Academic and Research Institutes
10.4.3.Cosmetics Industry
10.4.4.Healthcare Providers
10.4.5.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Organ On Chip Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Microfluidics-based Organ-on-Chip
11.1.2.3D Bioprinting-based Organ-on-Chip
11.1.3.Other
11.2.  Organ Types Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Liver-on-Chip
11.2.2.Brain-on-Chip
11.2.3.Lung-on-Chip
11.2.4.Heart-on-Chip
11.2.5.Kidney-on-Chip
11.2.6.Other Types
11.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Drug Discovery
11.3.2.Toxicology Research
11.3.3.Physiological Model Development
11.3.4.Disease Modelling
11.3.5.Personalized Medicine
11.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Pharmaceutical and Biotechnology Companies
11.4.2.Academic and Research Institutes
11.4.3.Cosmetics Industry
11.4.4.Healthcare Providers
11.4.5.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Organ On Chip Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Microfluidics-based Organ-on-Chip
12.1.2.3D Bioprinting-based Organ-on-Chip
12.1.3.Other
12.2.  Organ Types Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Liver-on-Chip
12.2.2.Brain-on-Chip
12.2.3.Lung-on-Chip
12.2.4.Heart-on-Chip
12.2.5.Kidney-on-Chip
12.2.6.Other Types
12.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Drug Discovery
12.3.2.Toxicology Research
12.3.3.Physiological Model Development
12.3.4.Disease Modelling
12.3.5.Personalized Medicine
12.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Pharmaceutical and Biotechnology Companies
12.4.2.Academic and Research Institutes
12.4.3.Cosmetics Industry
12.4.4.Healthcare Providers
12.4.5.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Organ On Chip Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Microfluidics-based Organ-on-Chip
13.1.2.3D Bioprinting-based Organ-on-Chip
13.1.3.Other
13.2.  Organ Types Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Liver-on-Chip
13.2.2.Brain-on-Chip
13.2.3.Lung-on-Chip
13.2.4.Heart-on-Chip
13.2.5.Kidney-on-Chip
13.2.6.Other Types
13.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Drug Discovery
13.3.2.Toxicology Research
13.3.3.Physiological Model Development
13.3.4.Disease Modelling
13.3.5.Personalized Medicine
13.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Pharmaceutical and Biotechnology Companies
13.4.2.Academic and Research Institutes
13.4.3.Cosmetics Industry
13.4.4.Healthcare Providers
13.4.5.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Organ On Chip Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Microfluidics-based Organ-on-Chip
14.1.2.3D Bioprinting-based Organ-on-Chip
14.1.3.Other
14.2.  Organ Types Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Liver-on-Chip
14.2.2.Brain-on-Chip
14.2.3.Lung-on-Chip
14.2.4.Heart-on-Chip
14.2.5.Kidney-on-Chip
14.2.6.Other Types
14.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Drug Discovery
14.3.2.Toxicology Research
14.3.3.Physiological Model Development
14.3.4.Disease Modelling
14.3.5.Personalized Medicine
14.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Pharmaceutical and Biotechnology Companies
14.4.2.Academic and Research Institutes
14.4.3.Cosmetics Industry
14.4.4.Healthcare Providers
14.4.5.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Allevi
15.2.2.Altis Biosystems
15.2.3.AlveoliX AG
15.2.4.AxoSim Technologies
15.2.5.BIOMIMESYS
15.2.6.CN Bio Innovations
15.2.7.Draper Laboratory
15.2.8.Elveflow
15.2.9.Emulate Inc.
15.2.10.Hesperos Inc.
15.2.11.Hesperos Inc.
16. Research Methodology 
17. Appendix and Abbreviations 
  • Allevi
  • Altis Biosystems
  • AlveoliX AG
  • AxoSim Technologies
  • BIOMIMESYS
  • CN Bio Innovations
  • Draper Laboratory
  • Elveflow
  • Emulate Inc.
  • Hesperos Inc.
  • Hesperos Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall
  • Kirkstall Ltd.
  • LifeNet Health LifeSciences
  • MIMETAS
  • Mimetas B.V.
  • Nortis Inc.
  • SynVivo Inc.
  • Tara Biosystems Inc.
  • TissUse GmbH
  • Vascular Dynamics
  • Xona Microfluidics

Adjacent Markets